ArticleProceedings of the National Academy of Sciences of the United States of America2025

Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cells.

Nils W Engel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.